Target intelligence / Profile preview

Nucleic acid synthesis enzyme (null)

Target
null
Molecular classification
Enzyme
01

Overview

Nucleic acid synthesis enzymes are a group of enzymes critical for the construction, modification, and degradation of nucleic acids (DNA and RNA) within cells[1][2][3][4][6]. The main types include DNA polymerases (which replicate and repair DNA), RNA polymerases (which transcribe DNA into RNA), nucleases (which cleave nucleic acid chains), and ligases (which join nucleic acid fragments)[1][3][4][6]. These enzymes underpin essential biological processes such as DNA replication, transcription, repair, recombination, and genetic regulation[2][6]. They are major therapeutic targets for antiviral, anticancer, and antimicrobial drugs that act via inhibition, misincorporation, or chain termination, but therapeutic use carries risks due to their central roles in normal cell proliferation and genome integrity[4][7]. Note: “Nucleic acid synthesis enzymes” is a category, not a single molecular target, so the entry describes a family rather than a specific enzyme. For structured data, use the individual canonical names (e.g., “DNA polymerase alpha,” “RNA polymerase II,” “HIV reverse transcriptase”) whenever possible for higher specificity.

Other names
DNA polymeraseRNA polymerasenucleaseDNA ligasenucleic acid polymerasenucleic acid joining enzyme
02

Mechanism of action

Inhibition of DNA polymerase; Inhibition of RNA polymerase; Chain termination; Nucleotide analog incorporation; DNA damage induction

03

Biological functions

DNA replicationRNA transcriptionDNA repairRNA processing and degradationRecombinationRegulation of gene expression
04

Disease associations

CancerInfectionGenetic disordersAntiviral resistanceNeurodegenerative disease
05

Safety considerations

Off-target toxicity in rapidly dividing cells (e.g., bone marrow suppression)Resistance development due to polymerase mutationsMitochondrial toxicity with some nucleoside analogsMutagenicity and carcinogenic risk
06

Interacting drugs

Acyclovir

8 more in the full profile.

07

Biomarkers

Mutations in polymerase genes (e.g., POLG mutations)Thymidine kinase activity (for herpesvirus susceptibility)

Beyond the preview

Go deeper on Nucleic acid synthesis enzyme (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleic acid synthesis enzyme (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call